Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin

NCT03250598 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Japanese
Non-Asian

Interventions

DRUG: AG-348
DRUG: AG-348
DRUG: AG-348

Sponsor

Agios Pharmaceuticals, Inc.